| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Pyrimethamine | GDSC1000 | pan-cancer | AAC | -0.0021 | 1 |
| mRNA | GDC-0941 | gCSI | pan-cancer | AAC | -0.0023 | 1 |
| mRNA | BRD-K33199242 | CTRPv2 | pan-cancer | AAC | -0.0014 | 1 |
| mRNA | KU-60019 | CTRPv2 | pan-cancer | AAC | -0.0013 | 1 |
| mRNA | foretinib | CTRPv2 | pan-cancer | AAC | -0.0013 | 1 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | 0.0011 | 1 |
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | -0.0011 | 1 |
| mRNA | GSK-1904529A | GDSC1000 | pan-cancer | AAC | 0.0011 | 1 |
| mRNA | NSC 74859 | CTRPv2 | pan-cancer | AAC | -0.0011 | 1 |
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | 0.00088 | 1 |